Antares Pharma, Inc. (NASDAQ:ATRS) has scheduled a conference call for 5th November 2020 at 8:30 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.antarespharma.com
Earnings Expectation
Antares Pharma, Inc. is expected to report third quarter earnings results, before market open, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.02 per share from revenue of $ 35.67 million. Looking ahead, the full year income are expected at $ 0.06 per share on the revenues of $ 140.95 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 135.00 million ~ $ 155.00 million
Click Here For More Historical Outlooks Of Antares Pharma, Inc.
Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The companys injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults.
